German Remedies launches new cancer drug
German Remedies, part of the Zydus Group, has announced the launch of Fludarabine, a drug used for the treatment of chronic lymphocytic leukaemia (blood cancer). The orally-administered drug, being
German Remedies, part of the Zydus Group, has announced the launch of Fludarabine, a drug used for the treatment of chronic lymphocytic leukaemia (blood cancer). The orally-administered drug, being